Suppr超能文献

呼吸衰竭重症患者的利尿剂联合使用:一项系统评价与荟萃分析

Diuretic combinations in critically ill patients with respiratory failure: A systematic review and meta-analysis.

作者信息

Côté Jean Maxime, Goulamhoussen Nadir, McMahon Blaithin A, Murray Patrick T

机构信息

Division of Nephrology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal H2X0C1, Québec, Canada.

Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, United States.

出版信息

World J Crit Care Med. 2022 May 9;11(3):178-191. doi: 10.5492/wjccm.v11.i3.178.

Abstract

BACKGROUND

In patients with respiratory failure, loop diuretics remain the cornerstone of the treatment to maintain fluid balance, but resistance is common.

AIM

To determine the efficacy and safety of common diuretic combinations in critically ill patients with respiratory failure.

METHODS

We searched MEDLINE, Embase, Cochrane Library and PROSPERO for studies reporting the effects of a combination of a loop diuretic with another class of diuretic. A meta-analysis using mean differences (MD) with 95% confidence interval (CI) was performed for the 24-h fluid balance (primary outcome) and the 24-h urine output, while descriptive statistics were used for safety events.

RESULTS

Nine studies totalling 440 patients from a total of 6510 citations were included. When compared to loop diuretics alone, the addition of a second diuretic is associated with an improved negative fluid balance at 24 h [MD: -1.06 L (95%CI: -1.46; -0.65)], driven by the combination of a thiazide plus furosemide [MD: -1.25 L (95%CI: -1.68; -0.82)], while no difference was observed with the combination of a loop-diuretic plus acetazolamide [MD: -0.40 L (95%CI: -0.96; 0.16)] or spironolactone [MD: -0.65 L (95%CI: -1.66; 0.36)]. Heterogeneity was high and the report of clinical and safety endpoints varied across studies.

CONCLUSION

Based on limited evidence, the addition of a second diuretic to a loop diuretic may promote diuresis and negative fluid balance in patients with respiratory failure, but only when using a thiazide. Further larger trials to evaluate the safety and efficacy of such interventions in patients with respiratory failure are required.

摘要

背景

在呼吸衰竭患者中,袢利尿剂仍然是维持液体平衡治疗的基石,但耐药现象很常见。

目的

确定常用利尿剂联合用药在重症呼吸衰竭患者中的疗效和安全性。

方法

我们检索了MEDLINE、Embase、Cochrane图书馆和PROSPERO,以查找报告袢利尿剂与另一类利尿剂联合用药效果的研究。对24小时液体平衡(主要结局)和24小时尿量进行了使用平均差(MD)及95%置信区间(CI)的荟萃分析,而对安全事件采用描述性统计。

结果

共纳入9项研究,涉及来自6510篇引文的440例患者。与单独使用袢利尿剂相比,加用第二种利尿剂可使24小时液体负平衡得到改善[平均差:-1.06升(95%置信区间:-1.46;-0.65)],这是由噻嗪类利尿剂加呋塞米的联合用药所致[平均差:-1.25升(95%置信区间:-1.68;-0.82)],而袢利尿剂加乙酰唑胺[平均差:-0.40升(95%置信区间:-0.96;0.16)]或螺内酯[平均差:-0.65升(95%置信区间:-1.66;0.36)]联合用药时未观察到差异。异质性较高,且各研究中临床和安全终点的报告有所不同。

结论

基于有限的证据,在袢利尿剂基础上加用第二种利尿剂可能会促进呼吸衰竭患者的利尿和液体负平衡,但仅在使用噻嗪类利尿剂时如此。需要进一步开展更大规模的试验来评估此类干预措施在呼吸衰竭患者中的安全性和疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/9136719/a13e73ada346/WJCCM-11-178-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验